For their study, researchers from Memorial Sloan-Kettering Cancer Center in New York City administered a single dose of clindamycin to a group of mice. Results showed the mice experienced weight loss, diarrhea and colitis and a 40-50 percent higher mortality rate. In addition, surviving mice remained susceptible to C. difficile infection for at least 28 days.
Related Articles on C. Difficile:
Varying Antibiotics Equally Effective in Treating Clostridium Difficile Infections